D
Sell
11/7/2022Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to D- from E+ on 11/7/2022 due to a noticeable increase in the growth index, solvency index and valuation index. Operating cash flow increased 111.89% from -$77.4 to $9.2.
E
Sell
3/22/2022Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to E+ from E on 3/22/2022 due to an increase in the volatility index and total return index.
E
Sell
3/7/2022Downgrade
Aion Therapeutic Inc. (ANTCF) was downgraded to E from E+ on 3/7/2022 due to a decline in the volatility index.
E
Sell
2/11/2022Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to E+ from E on 2/11/2022 due to an increase in the volatility index and total return index.
E
Sell
1/27/2022Downgrade
Aion Therapeutic Inc. (ANTCF) was downgraded to E from E+ on 1/27/2022 due to a decline in the volatility index.
E
Sell
1/3/2022Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to E+ from E on 1/3/2022 due to an increase in the valuation index.
E
Sell
10/1/2021Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to E from E- on 10/1/2021 due to an increase in the total return index, volatility index and valuation index.
E
Sell
7/16/2021None
Aion Therapeutic Inc. (ANTCF) was downgraded to E- from U on 07/16/2021.
